Part of the "Biographies of Disease" series, Parkinson's Disease is a straightforward presentation of what modern science and medicine has to tell us about the history, symptoms, causes, treatments, and natural course of Parkinson's Disease. Written in plain terms for readers of all backgrounds, Par
Parkinson's Disease
ā Scribed by Ronald F. Pfeiffer (ed.), Zbigniew K. Wszolek (ed.), Manuchair Ebadi (ed.)
- Publisher
- CRC Press
- Year
- 2012
- Tongue
- English
- Leaves
- 1319
- Edition
- 2nd
- Category
- Library
No coin nor oath required. For personal study only.
⦠Synopsis
In recent years, considerable advances have been made in our knowledge and understanding of Parkinson's disease (PD). In particular, there has been an explosion of information regarding genetic contributions to the etiology of PD and an increased awareness of the importance of the non-motor features of the disease. Theories regarding the pathogenesis and pathophysiology of PD have also been refined, and new treatment modalities and advances implemented. Reflecting these changes, this second edition features new chapters devoted to genetic aspects of PD, non-motor features of the disease, and aspects of the pathophysiology, pathogenesis, and treatment of PD.
⦠Table of Contents
Overview
James Parkinson
Jennifer G. Goldman and Christopher G. Goetz
Parkinsonās Disease: Where Have We Been?
Lawrence W. Elmer
Parkinsonās Disease: Where Are We?
Raúl de la Fuente-FernÔndez
Epidemiology
Epidemiology of Parkinsonās Disease: An Overview
Monica Korell and Caroline M. Tanner
Environmental Toxins and Parkinsonās Disease
Jason R. Cannon and Timothy J. Greenamyre
Rural Environment and Parkinsonās Disease
Daniel Strickland
Industrial and Occupational Exposures and Parkinson Disease
Samuel Goldman
Tetrahydroisoquinolines and Parkinsonās Disease
Mark S. LeDoux
Endogenous Neurotoxins in the Pathogenesis and Progression of Parkinsonās Disease
Shaik Shavali and Manuchair Ebadi
Genetics
Overview of the Genetics of Parkinsonism
Mathias Toft and Zbigniew K. Wszolek
α-Synuclein and Parkinsonās Disease
Thomas Gasser
LRRK2-Associated Parkinsonās Disease
Jonathan Carr and Soraya BardienParkin-Associated Parkinsonās Disease
Anne Grünewald and Christine KleinPINK1- and DJ-1-Linked Parkinsonism
Eng-King Tan
Genetic and Bioinformatic Tools in Parkinsonās Disease
Tatiana Foroud and Nathan Pankratz
Clinical Features of Parkinsonās Disease
Tremor, Rigidity, and Bradykinesia
Kelvin L. Chou and Howard I. Hurtig
Gait Disorders in Parkinsonās Disease
Yacov Balash, Jeffrey M. Hausdorff, Tanya Gurevich, and Nir Giladi
Somesthesia
Padraig OāSuilleabhain
Pain in Parkinsonās Disease
Blair Ford
Restless Legs Syndrome and Periodic Limb Movements of Sleep
Bryan T. Klassen and Charles H. Adler
Fatigue: A Common Comorbidity in Parkinsonās Disease
Anelyssa DāAbreu and Joseph H. Friedman
Visual Dysfunction in Parkinsonās Disease
Robert L. Rodnitzky
Visuo-Cognitive Dysfunctions in Parkinsonās Disease
Andrea Antal, Walter Paulus, and Ivan Bodis-Wollner
Olfactory Dysfunction in Parkinsonās Disease and Parkinsonian Syndromes
Katerina Markopoulou and Bruce A. Chase
Insomnia and Excessive Daytime Sleepiness in Parkinsonās Disease
J.A. Van Gerpen and Pablo Castillo
REM Sleep Behavior Disorder
Aleksandar Videnovic and Cynthia L. Comella
Gastrointestinal Dysfunction in Parkinsonās Disease
Ronald F. Pfeiffer
Urological Dysfunction
Carlos Singer and Henry Moore
Sexual Dysfunction
Cheryl Waters and Janice Smolowitz
Cardiovascular Autonomic Dysfunction in Parkinsonās Disease and Parkinsonian Syndromes
Valeria Iodice, David Low, Ekawat Vichayanrat, and Christopher J. Mathias
Disorders of Thermoregulation in Parkinsonās Disease
Thomas L. Davis
Respiratory Dysfunction
Holly Shill
Depression in Parkinsonās Disease
Steven P. Wengel, Dennis P. McNeilly, and William J. Burke
Anxiety and Parkinson Disease
Jeremy Quickfall, Michael Trew, and Oksana Suchowersky
Apathy in Parkinsonās Disease
Howard D. Weiss and Laura Marsh
Dementia
Anne L. Barba, B. Kelly Changizi, Donald S. Higgins, Stewart A. Factor, and Eric S. Molho
Pathophysiology of Parkinsonās Disease
Animal Models of Basal Ganglia Injury and Degeneration and Their Application to Parkinsonās Disease Research
Giselle M. Petzinger and Michael W. Jakowec
Neuroanatomy of Parkinsonās Disease
Heiko Braak and Kelly Del Tredici-Braak
Neuropathology of Parkinsonās Disease
John E. Duda and Dennis W. Dickson
Neurophysiology of the Motor Disorder in Parkinsonās Disease
Gaƫtan Garraux and Mark Hallett
Neurochemistry of Parkinsonās Disease: Dopamine
L. Charles Murrin
Pathophysiology of Parkinsonās Disease, Neurochemical Pathology: Other Neurotransmitters
Yoshikuni Mizuno
Theories of Pathogenesis
Oxidative Stress
Casey Cook and Leonard Petrucelli
Mitochondrial Dysfunction
Daniel G. Healy and A.H.V. Schapira
Excitotoxicity
Fabio Blandini
Inflammation
Roger Kurlan
Protein Conformational and Metabolic Changes in Parkinsonās Disease
Kevin St. P. McNaught and C. Warren Olanow
Cell Death in Parkinsonās Disease
Shankar Sadasivan, AnƩ Korff, Ciaran J. Faherty, and Richard Jay Smeyne
Diagnosis of Parkinsonās Disease
Differential Diagnosis of Parkinsonās Disease
Serena W. Hung and Anthony E. Lang
Neuroleptic-Induced Movement Disorders
Manuchair Ebadi
Clinical Diagnostic Criteria for Parkinsonās Disease
Daniel Tarsy and Laurie Gordon
Clinical Batteries and Biomarkers in the Diagnosis of Parkinsonās Disease
Claire Henchcliffe and Un Kang
Rating Scales
Kathleen M. Shannon
MR Imaging of Parkinsonism
James B. Wood
Molecular Imaging in Parkinson Disease
Danna Jennings, David Russell, Ken Marek, and John Seibyl
Positron Emission Tomography in Parkinsonās Disease
Silke Appel-Cresswell, R. Nandhagopal, John R. Adams, and A. Jon Stoessl
Transcranial Ultrasound in Parkinsonās Disease
Daniela Berg, Bettina Faust, and Alexandra Gaenslen
In Vivo Molecular Imaging in Parkinsonās Disease
Sushil K. Sharma and Manuchair Ebadi
Placebo Effect in Parkinsonās Disease
Jayasri Srinivasan, Sarah C. Lidstone, Raúl de la Fuente-FernÔndez, and A. Jon Stoessl
Treatment of Parkinsonās Disease with Anticholinergic Medications
Duarte Machado and Bahman Jabbari
Amantadine
Kelly E. Lyons and Rajesh Pahwa
MAO-B Inhibitors for the Treatment of Parkinsonās Disease
John Bertoni
Catechol-O-Methyltransferase Inhibitors in the Treatment of Parkinsonās Disease
Mervat Wahba, Theresa A. Zesiewicz, and Robert A. Hauser
Symptomatic Treatment of Parkinsonās Disease: Levodopa
John L. Goudreau and J. Eric Ahlskog
Dopamine Agonists in Parkinsonās Disease
Joseph Jankovic and Toby C. Yaltho
Non-Dopaminergic Drugs for Motor Symptoms
Pierre R. Burkhard and Francois J.G. Vingerhoets
Stereotactic Ablative Procedures for Intractable Parkinsonās Disease
Marco Sassi and Michael S. Okun
Deep Brain Stimulation Surgery
Ryan J. Uitti, Yashiko Baba, and Robert E. Wharen Jr.
Neurotransplantation in the Treatment of Parkinsonās Disease
Penelope Hallett and Ole Isacson
Role of Physical Therapy in Management of Parkinsonās Disease
Rose Wichmann
Speech Therapy in the Treatment of Parkinsonās Disease
Shimon Sapir, Lorraine Ramig, and Cynthia Fox
Dysphagia in Parkinsonās Disease
Lisa A. Newman
Restorative and Functional Occupational Therapy in Parkinsonās Disease
Surya Shah
Neurologic Music Therapy: A Modality to Address the Diverse Needs of People with Parkinsonās Disease
Sandra L. Holten
Dance for Persons with Parkinsonās Disease*
Olie Westheimer
Pathogenesis of Motor Response Complications in Parkinsonās Disease: "Mere Conjectural Suggestions" and Beyond
Leo Verhagen Metman and Christina L. Vaughan
Treatment of Early Parkinsonās Disease
John C. Morgan and Kapil D. Sethi
Treatment of Moderate Parkinsonās Disease
John E. Duda and Matthew B. Stern
Management of Advanced Parkinsonās Disease
Grace S. Lin Liang and James W. Tetrud
Role and Design of Clinical Trials for Parkinsonās Disease
Andrew Siderowf and Stanley Fahn
Future Symptomatic Therapy in Parkinsonās Disease
Ruth Djaldetti, Shlomit Yust-Katz, and Eldad Melamed
Calcium Influx, Free Radicals, and Aging: A Metabolic Burden Linked to Neuronal Loss in Parkinsonās Disease
Javier Sanchez-Padilla, Jaime N. Guzman, and D. James Surmeier
Therapeutic Potential of Exercise in Parkinsonās Disease
Brian K. Schilling
Gene Therapy for Parkinsonās: Disease from Bench to Bedside
Fredric P. Manfredsson, Aaron C. Rising, M. Angela Cenci, Carmen S. Peden, and Ronald J. Mandel
Translating Stem Cell Biology to Regenerative Medicine for Parkinsonās Disease
Florian A. Siebzehnrubl and Dennis A. Steindler
Alternative Drug Delivery in the Treatment of Parkinsonās Disease
Pierre J. Blanchet
Economics of Parkinsonās Disease
Jessica Mastalski, Robert G. Holloway, and Katia Noyes
Informal Caregiving: An Essential Part of the Team
Carmen Dyck and Susan M. Calne
Driving in Parkinsonās Disease
Ergun Y. Uc
Evolution and Potential of the National Parkinsonās Organizations: A Brief Overview
Ruth A. Hagestuen
Comprehensive Parkinsonās Disease Care in Complex Environments
Elaine Cohen, Monique Giroux, Ruth A. Hagestuen, and Gladys Gonzalez-Ramos
Index
š SIMILAR VOLUMES
Recent research is leading to an ever-increasing range of investigative approaches whose aim is to achieve effective neuroprotective or neurorestorative treatment for individuals affected by Parkinsonās disease. New directions under investigation reach beyond traditional pharmacological approaches t
The second title in the new series 'Clinician's Desk Reference', designed as concise up-to-date volumes on key conditions for physicians in the hospital setting and in primary care, and for many professionals allied to medicine. Coverage ranges from incidence, diagnosis, investigation, drug treatmen
<p>The youngest recorded case of Parkinson's disease was a 12-year-old patient, though the average age is around 56. With 50,000 cases a year, awareness of this disease is essential. There is now known cause of Parkinson's Disease, but there is a link between it and depression. Readers will explore